all stories

Revolution Medicines (NASDAQ:RVMD) Shares Up 3.4% on Analyst Upgrade

Steadysingle sourceOne outlet reported this, in 2 reports over 2 days - no second voice in this corpus.
Wed, 14 October 2026Thu, 22 October 2026

What it is about

Stephen KelseyMark GoldsmithSecurities Exchange CommissionNasdaqWolfe ResearchRevolution Medicines Company ProfileNorthwestern Mutual Wealth Management CoBurkett Financial ServicesRoyal BankMeeder Advisory Services IncGoldman Sachs GroupParagon Capital Management LtdCanadaAgios PharmaceuticalsUnited StatesCalifornia, United StatesRedwood City, California, United StatesMassachusetts, United StatesCambridge, Cambridgeshire, United Kingdom

Who published it, and when

original reportfirst to report
themarketsdaily.com1 original report1 original report
14 Oct, 15:41over 8 days22 Oct, 16:15

How it spread - 2 original reports

  1. Wed, 14 October 2026

    1 report
    • themarketsdaily.com15:41first to report

      Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report)’s stock price shot up 3.4% during trading on Wednesday after Royal Bank Of Canada raised their price target on the stock from $259.00 to $260.00. Royal Bank Of Canada currently has an outperform rating on the stock. Revolution Medicines traded as high as $197.00 and last traded […]

  2. Thu, 22 October 2026

    1 report
    • themarketsdaily.com16:15

      Revolution Medicines (NASDAQ:RVMD – Get Free Report) and Agios Pharmaceuticals (NASDAQ:AGIO – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, analyst recommendations, profitability and dividends. Profitability This table compares Revolution Medicines and Agios […]

One email a week

The stories everytrace watched stay alive - how many independent outlets carried each one, and how long it lasted. No daily digest, no breaking-news alerts.